Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal function in adolescents and adults with glycogen storage disease type Ia treated with captopril and indometacin
2006-000282-11Phase 2Active
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of captopril and indomethacin in glycogen storage disease type 1a (GSD1a) (3 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoints: Inulin clearance over three days and Urinary metabolite concentrations. Started Feb 2006; status: active.
02
Drugs
captoprilindomethacin
03
Conditions
glycogen storage disease type 1a (GSD1a)
Beyond the preview
Go deeper on 2006-000282-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000282-11.